IRHYTHM TECHNOLOGIES ($IRTC) posted quarterly earnings results for Q1 2026 on Thursday, April 30th. The company reported earnings of -$0.35 per share, beating estimates of -$0.66 by $0.31. The company also reported revenue of $199,390,000, beating estimates of $197,907,672 by $1,482,328.
Stock price change since market close: +2.07%
You can see Quiver Quantitative's $IRTC stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
IRHYTHM TECHNOLOGIES Insider Trading Activity
IRHYTHM TECHNOLOGIES insiders have traded $IRTC stock on the open market 46 times in the past 6 months. Of those trades, 0 have been purchases and 46 have been sales.
Here’s a breakdown of recent trading of $IRTC stock by insiders over the last 6 months:
- QUENTIN S. BLACKFORD (President and CEO) has made 0 purchases and 5 sales selling 53,412 shares for an estimated $7,804,679.
- DANIEL G. WILSON (Chief Financial Officer) has made 0 purchases and 6 sales selling 16,583 shares for an estimated $2,798,149.
- PATRICK MICHAEL MURPHY (CBO and CLO) has made 0 purchases and 5 sales selling 14,640 shares for an estimated $2,074,577.
- CHAD PATTERSON (CHIEF COMM & PRODUCT OFFICER) has made 0 purchases and 4 sales selling 13,691 shares for an estimated $1,836,857.
- ABHIJIT Y TALWALKAR has made 0 purchases and 10 sales selling 10,624 shares for an estimated $1,698,942.
- MINANG TURAKHIA (CHIEF MED/SCI OFCR EVP ADVTECH) has made 0 purchases and 4 sales selling 11,831 shares for an estimated $1,574,068.
- SUMI SHRISHRIMAL (EVP, Chief Risk Officer) has made 0 purchases and 4 sales selling 9,047 shares for an estimated $1,205,383.
- MERVIN SMITH (EVP Strategic Business Ops) has made 0 purchases and 4 sales selling 6,125 shares for an estimated $824,026.
- MARC WADE ROSENBAUM (Chief Accounting Officer) has made 0 purchases and 4 sales selling 5,893 shares for an estimated $793,874.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API.
IRHYTHM TECHNOLOGIES Hedge Fund Activity
We have seen 136 institutional investors add shares of IRHYTHM TECHNOLOGIES stock to their portfolio, and 176 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,450,386 shares (-63.6%) from their portfolio in Q4 2025, for an estimated $257,356,491
- RTW INVESTMENTS, LP added 1,181,990 shares (+inf%) to their portfolio in Q4 2025, for an estimated $209,732,305
- ARTISAN PARTNERS LIMITED PARTNERSHIP removed 1,055,521 shares (-41.1%) from their portfolio in Q4 2025, for an estimated $187,291,646
- MILLENNIUM MANAGEMENT LLC added 548,519 shares (+197.4%) to their portfolio in Q4 2025, for an estimated $97,329,211
- SANDS CAPITAL MANAGEMENT, LLC removed 536,465 shares (-24.0%) from their portfolio in Q4 2025, for an estimated $95,190,349
- CHAMPLAIN INVESTMENT PARTNERS, LLC removed 365,627 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $64,876,854
- JPMORGAN CHASE & CO added 319,149 shares (+72.6%) to their portfolio in Q4 2025, for an estimated $56,629,798
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
IRHYTHM TECHNOLOGIES Analyst Ratings
Wall Street analysts have issued reports on $IRTC in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Truist Securities issued a "Buy" rating on 12/18/2025
To track analyst ratings and price targets for IRHYTHM TECHNOLOGIES, check out Quiver Quantitative's $IRTC forecast page.
IRHYTHM TECHNOLOGIES Price Targets
Multiple analysts have issued price targets for $IRTC recently. We have seen 10 analysts offer price targets for $IRTC in the last 6 months, with a median target of $200.0.
Here are some recent targets:
- Richard Newitter from Truist Securities set a target price of $170.0 on 04/15/2026
- David Roman from Goldman Sachs set a target price of $147.0 on 04/09/2026
- Vijay Kumar from Evercore ISI Group set a target price of $170.0 on 04/06/2026
- Joanne Wuensch from Citigroup set a target price of $214.0 on 03/11/2026
- Nathan Treybeck from Wells Fargo set a target price of $200.0 on 02/20/2026
- Mike Polark from Baird set a target price of $200.0 on 02/20/2026
- Allen Gong from JP Morgan set a target price of $215.0 on 02/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
